Cue Biopharma (CUE) Interest Expenses (2022)

Cue Biopharma's (CUE) quarterly Interest Expenses came in at $124000.0 in Q3 2022, down 39.81% quarter-over-quarter from $206000.0 in Q2 2022.

Cue Biopharma (CUE) Interest Expenses (2022) Analysis & Trends

Cue Biopharma has disclosed Interest Expenses across 1 years of filings, most recently posting $124000.0 for Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-5.50 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-332,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	61,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-5.58 Mn
10	Cue Biopharma	581.16 Mn	553.47 Mn	-	-

Download Data